Toggle navigation
Pipeline
Pipeline
Pipeline Chart
Validive
Overview
Severe Oral Mucositis and Oropharyngeal Cancer
Phase 2 Data Supports Further Development in OPC
MNPR-301-001 Clinical Trial
Camsirubicin
Overview
Clinical Data
Development Strategy
MNPR-201-001 Clinical Trial
MNPR-101 RIT & MNPR-101-Zr
MNPR-101
Overview
Development Strategy
MNPR-202
Collaborations
Overview
Current Collaborations
Intellectual Property
Publications
Validive
Camsirubicin
MNPR-101
Investors
Investors
Overview
Annual Meeting
News / Events
Press Releases
IR Calendar
In the News
Email Alerts
Company Information
Profile
Presentations
Our Team
FAQ
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Our Team
Our Team
Contact Us
Contact Us
SIV Materials
SIV Materials
Home
Investors
Company Information
Presentations
Investors
Investors
Overview
Annual Meeting
News / Events
Press Releases
IR Calendar
In the News
Email Alerts
Company Info
Profile
Presentations
Our Team
FAQ
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Company Information
Profile
Presentations
Our Team
FAQ
Presentations
Corporate Presentation August 2022
